These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38527615)

  • 1. Prevalence of long COVID in the general adult population according to different definitions and sociodemographic and infection characteristics. A nationwide random sampling survey in France in autumn 2022.
    Coste J; Delpierre C; Richard JB; Alleaume C; Gallay A; Tebeka S; Lemogne C; Robineau O; Steichen O; Makovski TT
    Clin Microbiol Infect; 2024 Jul; 30(7):924-929. PubMed ID: 38527615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Post-COVID conditions among Mexican COVID-19 survivors: a nationwide cross-sectional study.
    Ramírez-Toscano Y; Torres-Ibarra L; Carnalla M; Basto-Abreu A; Vidaña-Perez D; Colchero MA; Bautista-Arredondo S; Saydah S; Barrientos-Gutiérrez T
    BMC Public Health; 2024 Jun; 24(1):1729. PubMed ID: 38943168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
    Pinato DJ; Tabernero J; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Saponara M; Cruz CA; García-Illescas D; Felip E; Roqué Lloveras A; Sharkey R; Roldán E; Reyes R; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Cantini L; Filetti M; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Van Hemelrijck M; Diamantis N; Newsom-Davis T; Gennari A; Cortellini A;
    Lancet Oncol; 2021 Dec; 22(12):1669-1680. PubMed ID: 34741822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of post-COVID-19 condition on health status and activities of daily living: the PRIME post-COVID study.
    Van Herck M; Pagen DME; van Bilsen CJA; Brinkhues S; Konings K; den Heijer CDJ; Mujakovic S; Ter Waarbeek HLG; Burtin C; Janssen DJA; Hoebe CJPA; Spruit MA; Dukers-Muijrers NHTM
    Thorax; 2024 Apr; 79(5):457-464. PubMed ID: 38499346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric Symptoms, Treatment Uptake, and Barriers to Mental Health Care Among US Adults With Post-COVID-19 Condition.
    Naik H; Tran KC; Staples JA; Perlis RH; Levin A
    JAMA Netw Open; 2024 Apr; 7(4):e248481. PubMed ID: 38662370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidimensional Sleep Health Prior to SARS-CoV-2 Infection and Risk of Post-COVID-19 Condition.
    Wang S; Huang T; Weisskopf MG; Kang JH; Chavarro JE; Roberts AL
    JAMA Netw Open; 2023 May; 6(5):e2315885. PubMed ID: 37252741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 testing, infection and places of contamination in France, a national cross-sectional study, December 2021.
    Vaux S; Gautier A; Soullier N; Levy-Bruhl D
    BMC Infect Dis; 2023 May; 23(1):279. PubMed ID: 37138208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey.
    Woldegiorgis M; Cadby G; Ngeh S; Korda RJ; Armstrong PK; Maticevic J; Knight P; Jardine A; Bloomfield LE; Effler PV
    Med J Aust; 2024 Apr; 220(6):323-330. PubMed ID: 38508863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults.
    Selvakumar J; Havdal LB; Drevvatne M; Brodwall EM; Lund Berven L; Stiansen-Sonerud T; Einvik G; Leegaard TM; Tjade T; Michelsen AE; Mollnes TE; Lund-Johansen F; Holmøy T; Zetterberg H; Blennow K; Sandler CX; Cvejic E; Lloyd AR; Wyller VBB
    JAMA Netw Open; 2023 Mar; 6(3):e235763. PubMed ID: 36995712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
    Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
    JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
    Matta J; Wiernik E; Robineau O; Carrat F; Touvier M; Severi G; de Lamballerie X; Blanché H; Deleuze JF; Gouraud C; Hoertel N; Ranque B; Goldberg M; Zins M; Lemogne C;
    JAMA Intern Med; 2022 Jan; 182(1):19-25. PubMed ID: 34747982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
    Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
    EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022.
    Qasmieh SA; Robertson MM; Teasdale CA; Kulkarni SG; Jones HE; McNairy M; Borrell LN; Nash D
    Prev Med; 2023 Apr; 169():107461. PubMed ID: 36813250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey.
    Pouwels KB; House T; Pritchard E; Robotham JV; Birrell PJ; Gelman A; Vihta KD; Bowers N; Boreham I; Thomas H; Lewis J; Bell I; Bell JI; Newton JN; Farrar J; Diamond I; Benton P; Walker AS;
    Lancet Public Health; 2021 Jan; 6(1):e30-e38. PubMed ID: 33308423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.